| Year |
Citation |
Score |
| 2024 |
Martínez A, Gaspar PA, Bermudez DH, Belen Aburto-Ponce M, Beggel O, Javitt DC. Disrupted third visual pathway function in schizophrenia: Evidence from real and implied motion processing. Neuroimage. Clinical. 41: 103570. PMID 38309185 DOI: 10.1016/j.nicl.2024.103570 |
0.603 |
|
| 2023 |
Martínez A, Gaspar PA, Bermudez DH, Aburto-Ponce MB, Javitt DC. Bottom-up and top-down contributions to impaired motion processing in schizophrenia. Medrxiv : the Preprint Server For Health Sciences. PMID 37461678 DOI: 10.1101/2023.07.07.23292259 |
0.638 |
|
| 2022 |
Martínez A, Tobe RH, Gaspar PA, Malinsky D, Dias EC, Sehatpour P, Lakatos P, Patel GH, Bermudez DH, Silipo G, Javitt DC. Disease-Specific Contribution of Pulvinar Dysfunction to Impaired Emotion Recognition in Schizophrenia. Frontiers in Behavioral Neuroscience. 15: 787383. PMID 35237135 DOI: 10.3389/fnbeh.2021.787383 |
0.614 |
|
| 2021 |
Nieto RR, Carrasco A, Corral S, Castillo R, Gaspar PA, Bustamante ML, Silva H. BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review. Frontiers in Psychiatry. 12: 662407. PMID 34220575 DOI: 10.3389/fpsyt.2021.662407 |
0.423 |
|
| 2020 |
Langer ÁI, Schmidt C, Vergara R, Mayol-Troncoso R, Lecaros J, Krogh E, Vergara C, Díaz M, Rivera G, Aguirre-Baez R, Gaspar PA. Examining the effect of a mindfulness based program for the improvement of cognitive function in an early stage of schizophrenia. A random controlled trial. Schizophrenia Research. PMID 32763112 DOI: 10.1016/J.Schres.2020.07.012 |
0.447 |
|
| 2018 |
Gaspar PA, Castillo RI, Maturana A, Villar MJ, Ulloa K, González G, Ibaceta O, Ortiz A, Corral S, Mayol R, De Angel V, Aburto MB, Martínez A, Corcoran CM, Silva H. Early psychosis detection program in Chile: A first step for the South American challenge in psychosis research. Early Intervention in Psychiatry. PMID 30548415 DOI: 10.1111/Eip.12766 |
0.515 |
|
| 2018 |
Martínez A, Gaspar PA, Hillyard SA, Andersen SK, Lopez-Calderon J, Corcoran CM, Javitt DC. Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications. The American Journal of Psychiatry. appiajp201818010072. PMID 30278791 DOI: 10.1176/Appi.Ajp.2018.18010072 |
0.715 |
|
| 2017 |
Bustamante ML, Herrera L, Gaspar PA, Nieto R, Maturana A, Villar MJ, Salinas V, Silva H. Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 174: 663-670. PMID 28901686 DOI: 10.1002/Ajmg.B.32550 |
0.352 |
|
| 2017 |
Corral SA, de Angel V, Salas N, Zúñiga-Venegas L, Gaspar PA, Pancetti F. Cognitive impairment in agricultural workers and nearby residents exposed to pesticides in the Coquimbo Region of Chile. Neurotoxicology and Teratology. PMID 28579518 DOI: 10.1016/J.Ntt.2017.05.003 |
0.314 |
|
| 2017 |
Langer ÁI, Schmidt C, Mayol R, Díaz M, Lecaros J, Krogh E, Pardow A, Vergara C, Vergara G, Pérez-Herrera B, Villar MJ, Maturana A, Gaspar PA. The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: study protocol for a randomized controlled trial. Trials. 18: 233. PMID 28545578 DOI: 10.1186/S13063-017-1967-7 |
0.405 |
|
| 2016 |
Castillo RI, Rojo LE, Henriquez-Henriquez M, Silva H, Maturana A, Villar MJ, Fuentes M, Gaspar PA. From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism. Frontiers in Neuroscience. 10: 488. PMID 27877101 DOI: 10.3389/Fnins.2016.00488 |
0.322 |
|
| 2015 |
Rojo LE, Gaspar PA, Silva H, Risco L, Arena P, Cubillos-Robles K, Jara B. Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology. Pharmacological Research. 101: 74-85. PMID 26218604 DOI: 10.1016/J.Phrs.2015.07.022 |
0.334 |
|
| 2015 |
Martínez A, Gaspar PA, Hillyard SA, Bickel S, Lakatos P, Dias EC, Javitt DC. Neural oscillatory deficits in schizophrenia predict behavioral and neurocognitive impairments. Frontiers in Human Neuroscience. 9: 371. PMID 26190988 DOI: 10.3389/Fnhum.2015.00371 |
0.678 |
|
| 2012 |
Gaspar PA, Bustamante ML, Rojo LE, Martinez A. From glutamatergic dysfunction to cognitive impairment: boundaries in the therapeutic of the schizophrenia. Current Pharmaceutical Biotechnology. 13: 1543-8. PMID 22283759 DOI: 10.2174/138920112800784790 |
0.592 |
|
| 2011 |
Gaspar PA, Bosman CA, Ruiz S, Zamorano F, Pérez C, Aboitiz F. Parametric increases of working memory load unveil a decreased alpha oscillatory activity in schizophrenia. Schizophrenia Research. 131: 268-9. PMID 21741218 DOI: 10.1016/J.Schres.2011.06.010 |
0.691 |
|
| 2011 |
Gaspar PA, Ruiz S, Zamorano F, Altayó M, Pérez C, Bosman CA, Aboitiz F. P300 amplitude is insensitive to working memory load in schizophrenia. Bmc Psychiatry. 11: 29. PMID 21324141 DOI: 10.1186/1471-244X-11-29 |
0.667 |
|
| 2009 |
Gaspar PA, Bustamante ML, Silva H, Aboitiz F. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications. Journal of Neurochemistry. 111: 891-900. PMID 19686383 DOI: 10.1111/J.1471-4159.2009.06325.X |
0.62 |
|
| 2009 |
Gaspar PA, Bosman C, Ruiz S, Aboitiz F. The aberrant connectivity hypothesis in schizophrenia From Attention to Goal-Directed Behavior: Neurodynamical, Methodological and Clinical Trends. 301-323. DOI: 10.1007/978-3-540-70573-4_15 |
0.7 |
|
| Show low-probability matches. |